Cursor used agents to write a browser, proving AI can write shoddy code at scale

Project kind-of worked but left a lot of messes for humans to clean up A week ago, Cursor CEO Michael Truell celebrated what ...
Pharmabiz

IntraBio’s Aqneursa receives European Commission’s marketing approval for treatment of ...

IntraBio’s Aqneursa receives European Commission’s marketing approval for treatment of Niemann-Pick Type C disease: Austin, Texas Saturday, January 24, 2026, 14:00 Hrs [IST] I ...

IntraBio Inc.: IntraBio Receives European Commission Approval of AQNEURSA for the Treatment ...

IntraBio Inc. today announced that the European Commission granted marketing authorization to AQNEURSA(levacetylleucine) for the treatment of neurological manifestations of Niemann-Pick Type C (NPC) ...